PATHOPHARMACOLOGICAL FOUNDATIONS FOR ADVANCED NURSING PRACTICE

PATHOPHARMACOLOGICAL FOUNDATIONS FOR ADVANCED NURSING PRACTICE

Competencies:
7002.1.1: Pathophysiology – The graduate evaluates high volume, high impact disease processes, including associated pharmacological interventions and implications for advanced practice.
7002.1.2: Evaluation of Pharmaceutical Impact – The graduate analyzes pharmaceutical impacts, including physiological, psychological, financial, and lifestyle factors on the selected disease processes.
7002.1.3: Managing Care Transitions – The graduate evaluates salient pharmacological issues in managing patient care transitions.
7002.1.4: Salience – The graduate distinguishes between general information and relevant assessment findings to manage and minimize pathologies and risk factors to promote optimal patient outcomes.
7002.1.5: Care Management – The graduate integrates relevant patient and population data to develop pathopharmacological management strategies for populations.

Introduction:

As an advanced practice nurse, it is important to diagnose, treat, and evaluate patients who have chronic disease. A nurse must understand how pathology, treatment, regimens, and psycho-social issues affect patients and the care they receive. Disease management is more than just monitoring a medication or treatment; it is evaluating the disease process from the micro to macro level. As a nurse with an advanced degree, you will be expected to assess patients and individual and population responses to chronic illness.

For this assessment, you will investigate pathopharmacological issues related to a specific disease process. You may choose to investigate traumatic brain injury, depression, obesity, asthma, or heart disease. As part of this assessment, you will analyze the various impacts the disease process has on the patients, their families, and populations at a local, national, and international level.

Requirements:

A. Investigate one of the following disease processes: traumatic brain injury, depression, obesity, asthma, or heart disease.

1. Analyze the pathophysiology of the disease process you selected in part A.

2. Discuss the standard of practice for the selected disease process.

a. Discuss the evidence-based pharmacological treatments in your state and how they affect management of the selected disease in your community.

b. Discuss clinical guidelines for assessment, diagnosis, and patient education for the selected disease process.

c. Compare the standard practice for managing the disease within your community with state or national practices.

3. Discuss characteristics of and resources for a patient who manages the selected disease well, including access to care, treatment options, life expectancy, and outcomes.

a. Analyze disparities between management of the selected disease on a national and international level.

4. Discuss three or four factors (e.g., financial resources, access to care, insured/uninsured, Medicare/Medicaid) that contribute to a patient being able to manage the selected disease

a. Explain how a lack of the factors discussed in part A4 leads to an unmanaged disease process.

i. Describe characteristics of a patient with the selected disease that is unmanaged.

B. Analyze how the selected disease process affects patients, families, and populations in your community.

1. Discuss the financial costs associated with the selected disease process for patients, families, and populations from diagnosis to treatment.

C. Discuss how you will promote best practices for managing the selected disease in your current healthcare organization.

1. Discuss three strategies you could use to implement best practices for managing the selected disease in your current healthcare organization.

2. Discuss an appropriate method to evaluate the implementation of each of the strategies from part C1.

D. When you use sources, include all in-text citations and references in APA format.

Note: For definitions of terms commonly used in the rubric, see the Rubric Terms web link included in the Evaluation Procedures section.

Note: When using sources to support ideas and elements in an assessment, the submission MUST include APA formatted in-text citations with a corresponding reference list for any direct quotes or paraphrasing. It is not necessary to list sources that were consulted if they have not been quoted or paraphrased in the text of the assessment.

Note: No more than a combined total of 30% of a submission can be directly quoted or closely paraphrased from outside sources, even if cited correctly. For tips on using APA style, please refer to the APA Handout web link included in the APA Guidelines section.

Rublic

Note You may wish to change your printer settings to “landscape” mode if you have a rubric with many levels. Send to Printer Now
Created with Taskstream WUT Task 1
Export to Word link opens in new window
value: 0.00 value: 1.00 value: 2.00 value: 3.00 value: 4.00 Score/Level
Articulation of Response (clarity, organization, mechanics)
The candidate provides unsatisfactory articulation of response. The candidate provides weak articulation of response. The candidate provides limited articulation of response. The candidate provides adequate articulation of response. The candidate provides substantial articulation of response.
A. Investigated Disease Process
The candidate does not investigate 1 of the given disease processes. Not applicable. Not applicable. Not applicable. The candidate investigates 1 of the given disease processes.
A1. Pathophysiology
The candidate does not provide a plausible analysis of the pathophysiology of the disease process selected in part A. The candidate provides a plausible analysis, with no detail, of the pathophysiology of the disease process selected in part A. The candidate provides a plausible analysis, with limited detail, of the pathophysiology of the disease process selected in part A. The candidate provides a plausible analysis, with adequate detail, of the pathophysiology of the disease process selected in part A. The candidate provides a plausible analysis, with substantial detail, of the pathophysiology of the disease process selected in part A.
A2. Standard of Practice
The candidate does not provide a logical discussion of the standard of practice for the selected disease process. The candidate provides a logical discussion, with no detail, of the standard of practice for the selected disease process. The candidate provides a logical discussion, with limited detail, of the standard of practice for the selected disease process. The candidate provides a logical discussion, with adequate detail, of the standard of practice for the selected disease process. The candidate provides a logical discussion, with substantial detail, of the standard of practice for the selected disease process.
A2a. Pharmacological Treatments
The candidate does not provide a logical discussion of the evidence-based pharmacological treatments in the candidate�s state and how they affect management of the selected disease in the candidate�s community. The candidate provides a logical discussion, with no detail, of the evidence-based pharmacological treatments in the candidate�s state and how they affect management of the selected disease in the candidate�s community. The candidate provides a logical discussion, with limited detail, of the evidence-based pharmacological treatments in the candidate�s state and how they affect management of the selected disease in the candidate�s community. The candidate provides a logical discussion, with adequate detail, of the evidence-based pharmacological treatments in the candidate�s state and how they affect management of the selected disease in the candidate�s community. The candidate provides a logical discussion, with substantial detail, of the evidence-based pharmacological treatments in the candidate�s state and how they affect management of the selected disease in the candidate�s community.
A2b. Clinical Guidelines
The candidate does not provide a logical discussion of clinical guidelines for assessment, diagnosis, and patient education for the selected disease process. The candidate provides a logical discussion, with no detail, of clinical guidelines for assessment, diagnosis, and patient education for the selected disease process. The candidate provides a logical discussion, with limited detail, of clinical guidelines for assessment, diagnosis, and patient education for the selected disease process. The candidate provides a logical discussion, with adequate detail, of clinical guidelines for assessment, diagnosis, and patient education for the selected disease process. The candidate provides a logical discussion, with substantial detail, of clinical guidelines for assessment, diagnosis, and patient education for the selected disease process.
A2c. Standard Practice of Disease Management
The candidate does not provide an appropriate comparison of standard practice for managing the disease within the candidate�s community with state or national practices. The candidate provides an appropriate comparison, with no detail, of standard practice for managing the disease within the candidate�s community with state or national practices. The candidate provides an appropriate comparison, with limited detail, of standard practice for managing the disease within in the candidate�s community with state or national practices. The candidate provides an appropriate comparison, with adequate detail, of standard practice for managing the disease within the candidate�s community with state or national practices. The candidate provides an appropriate comparison, with substantial detail, of standard practice for managing the disease within the candidate�s community with state or national practices.
A3. Managed Disease Process
The candidate does not provide a logical discussion of characteristics of and resources for a patient who manages the selected disease well, including access to care, treatment options, life expectancy, and outcomes. The candidate provides a logical discussion, with no detail, of characteristics of and resources for a patient who manages the selected disease well, including access to care, treatment options, life expectancy, and outcomes. The candidate provides a logical discussion, with limited detail, of characteristics of and resources for a patient who manages the selected disease well, including access to care, treatment options, life expectancy, and outcomes. The candidate provides a logical discussion, with adequate detail, of characteristics of and resources for a patient who manages the selected disease well, including access to care, treatment options, life expectancy, and outcomes. The candidate provides a logical discussion, with substantial detail, of characteristics of and resources for a patient who manages the selected disease well, including access to care, treatment options, life expectancy, and outcomes.
A3a. Disparities
The candidate does not provide a plausible analysis of disparities between management of the selected disease on a national and international level. The candidate provides a plausible analysis, with no support, of disparities between management of the selected disease on a national and international level. The candidate provides a plausible analysis, with limited support, of disparities between management of the selected disease on a national and international level. The candidate provides a plausible analysis, with adequate support, of disparities between management of the selected disease on a national and international level. The candidate provides a plausible analysis, with substantial support, of disparities between management of the selected disease on a national and international level.
A4. Managed Disease Factors
The candidate does not provide a logical discussion, of any factors that contribute to a patient being able to manage the selected disease. The candidate provides a logical discussion, with sufficient detail, of 1 or 2 factors that contribute to a patient being able to manage the selected disease. Not applicable. Not applicable. The candidate provides a logical discussion, with sufficient detail, of 3 or 4 factors that contribute to a patient being able to manage the selected disease.
A4a. Unmanaged Disease Factors
The candidate does not provide a logical explanation of how a lack of the factors discussed in part A4 leads to an unmanaged disease process. The candidate provides a logical explanation, with no detail, of how a lack of the factors discussed in part A4 leads to an unmanaged disease process. The candidate provides a logical explanation, with limited detail, of how a lack of the factors discussed in part A4 leads to an unmanaged disease process. The candidate provides a logical explanation, with adequate detail, of how a lack of the factors discussed in part A4 leads to an unmanaged disease process. The candidate provides a logical explanation, with substantial detail, of how a lack of the factors discussed in part A4 leads to an unmanaged disease process.
A4ai. Unmanaged Disease Characteristics
The candidate does not provide an appropriate description of the characteristics of a patient with the selected disease that is unmanaged. Not applicable. The candidate provides an appropriate description, with insufficient detail, of the characteristics of a patient with the selected disease that is unmanaged. Not applicable. The candidate provides an appropriate description, with sufficient detail, of the characteristics of a patient with the selected disease that is unmanaged.
B. Patients, Families, & Populations
The candidate does not provide a plausible analysis of how the selected disease process affects patients, families, and populations in the candidate�s community. The candidate provides a plausible analysis, with no detail, of how the selected disease process affects patients, families, and populations in the candidate�s community. The candidate provides a plausible analysis, with limited detail, of how the selected disease process affects patients, families, and populations in the candidate�s community. The candidate provides a plausible analysis, with adequate detail, of how the selected disease process affects patients, families, and populations in the candidate�s community. The candidate provides a plausible analysis, with substantial detail, of how the selected disease process affects patients, families, and populations in the candidate�s community.
B1. Costs
The candidate does not provide a logical discussion of the financial costs associated with the selected disease process for patients, families, and populations from diagnosis to treatment. The candidate provides a logical discussion, with no detail, of the financial costs associated with the selected disease process for patients, families, and populations from diagnosis to treatment. The candidate provides a logical discussion, with limited detail, of the financial costs associated with the selected disease process for patients, families, and populations from diagnosis to treatment. The candidate provides a logical discussion, with adequate detail, of the financial costs associated with the selected disease process for patients, families, and populations from diagnosis to treatment. The candidate provides a logical discussion, with substantial detail, of the financial costs associated with the selected disease process for patients, families, and populations from diagnosis to treatment.
C. Best Practices Promotion
The candidate does not provide a logical discussion of how the candidate will promote best practices for managing the selected disease in the candidate�s current healthcare organization. The candidate provides a logical discussion, with no detail, of how the candidate will promote best practices for managing the selected disease in the candidate�s current healthcare organization. The candidate provides a logical discussion, with limited detail, of how the candidate will promote best practices for managing the selected disease in the candidate�s current healthcare organization. The candidate provides a logical discussion, with adequate detail, of how the candidate will promote best practices for managing the selected disease in the candidate�s current healthcare organization. The candidate provides a logical discussion, with substantial detail, of how the candidate will promote best practices for managing the selected disease in the candidate�s current healthcare organization.
C1. Implementation Plan
The candidate does not provide a discussion of 3 strategies the candidate could use to implement best practices for managing the selected disease in the candidate�s current healthcare organization. The candidate provides a logical discussion, with no detail, of 3 strategies the candidate could use to implement best practices for managing the selected disease in the candidate�s current healthcare organization. The candidate provides logical discussion, with limited detail, of 3 strategies the candidate could use to implement best practices for managing the selected disease in the candidate�s current healthcare organization. The candidate provides a logical discussion, with adequate detail, of 3 strategies the candidate could use to implement best practices for managing the selected disease in the candidate�s current healthcare organization. The candidate provides a logical discussion, with substantial detail, of 3 strategies the candidate could use to implement best practices for managing the selected disease in the candidate�s current healthcare organization.
C2. Evaluation Method
The candidate does not provide a logical discussion of an appropriate method to evaluate the implementation of each of the strategies from part C1. The candidate provides a logical discussion, with no detail, of an appropriate method to evaluate the implementation of each of the strategies from part C1. The candidate provides a logical discussion, with limited detail, of an appropriate method to evaluate the implementation of each of the strategies from part C1. The candidate provides a logical discussion, with adequate detail, of an appropriate method to evaluate the implementation of each of the strategies from part C1. The candidate provides a logical discussion, with substantial detail, of an appropriate method to evaluate the implementation of each of the strategies from part C1.
D. Sources
When the candidate uses sources, the candidate does not provide in-text citations and references. When the candidate uses sources, the candidate provides only some in-text citations and references. When the candidate uses sources, the candidate provides appropriate in-text citations and references with major deviations from APA style. When the candidate uses sources, the candidate provides appropriate in-text citations and references with minor deviations from APA style. When the candidate uses sources, the candidate provides appropriate in-text citations and references with no readily detectable deviations from APA style, OR the candidate does not use sources.